Single-tablet HIV Treatment Shows Better Outcomes Over Multi-tablet Regimen | Latest News RSS feed

Single-tablet HIV Treatment Shows Better Outcomes Over Multi-tablet Regimen - Latest News


Single-tablet HIV treatment shows better outcomes over multi-tablet regimen

HIV patients on a single-tablet daily regimen had better treatment retention and viral suppression than patients taking multiple pills, in a study by a Michael E. DeBakey Veterans Affairs Medical Cent... read more

Janssen's New Darunavir-Based Single Tablet Regimen SYMTUZA® Shows Positive Outcome in Treatment of Antiretroviral-Naïve HIV Patients

Findings from the study demonstrated that the single tablet regimen (STR) D/C/F/TAFprovided effective ... and safety of D/C/F/TAF versus the control in HIV-1 positive treatment-naïve adult patients ov... read more

Not Only Are Once-A-Day Pills For Combating HIV Less Expensive Than Other Regimens, Patients Are More Likely To Take Them

Stat: Once-A-Day Pills For Combating HIV ... multi-tablet regimens and also offer an added bonus — patient adherence is greater, which suggests healthier outcomes, according to a new analysis of pharm... read more

Looking for another news?


Gilead: The Good, The 'Meh' And The Ugly

TAF's ultra-low 10-25 mg dose allows Biktarvy to set two new standards for a GILD single tablet regimen for HIV ... may also be used off label in resistant HIV cases as part of an individualized, mult... read more


Choices, choices: the rapidly evolving HIV treatment landscape

The advent of the Single Tablet Regimen (STR) offered a revolutionary alternative ... STRs result in improved adherence and better treatment outcomes. The EU5's first STR – Atripla – was launched by a ... read more

JAIDS Journal of Acquired Immune Deficiency Syndromes:

In this treatment-experienced population of HIV-infected women in the United States, we found that single-tablet regimen ... follow over time. Future work should also follow the outcomes of previously ... read more

Pharm Exec's 2015 Brand of the Year: Sovaldi and Harvoni for Hepatitis C

And while Gilead remains tightly focused on the anti-viral business, HCV has—at least for the moment—eclipsed the company’s traditional weight in the HIV ... single tablet, administered orally for a s... read more

Gilead Sciences Management Discusses Q3 2012 Results - Earnings Call Transcript

Total utilization of single tablet regimens for naive patients was boosted by Eviplera to a new high of nearly 30%. Eviplera is now the #2 regimen in HIV naive patients ... depending on the outcome. I... read more

HIV Treatment Adds Safe Once-a-Day Pill

But the findings are still beneficial, as evidence shows people who receive treatment for HIV do better with single-tablet, once-daily dosing ... Ultimately, the regimen can improve a patient's outcom... read more

WAVES shows elvitegravir regimen beats boosted atazanavir for women with HIV

HIV treatment is not a cure, but it is keeping millions of people well. Start learning about it in this section. Just diagnosed In this section we have answered some of the questions you might have if ... read more

Gilead Sciences' (GILD) Management Presents at Piper Jaffray Healthcare Conference (Transcript)

We have multiple Phase 2 efforts going on in Hepatitis B a disease that affects over ... step in HIV treatment history and highly significant for better patient outcomes. So in HIV, Stribild is our ne... read more

Better outcomes for patients using single-pill combination for blood pressure

People who are prescribed a combination pill to manage their high blood pressure are more likely to take their medicine as instructed and have better health outcomes than ... saving one in 40 lives ov... read more



FeedsRSS Created by. Full RSS Feed | Privacy Policy | Contact Us